[PHARMA] QoQ Cumulative Quarter Result on 31-Mar-2010 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
26-May-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
31-Mar-2010 [#1]
Profit Trend
QoQ- -84.54%
YoY- -35.91%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
Revenue 1,378,348 1,002,232 667,895 317,560 1,300,796 976,890 646,928 65.34%
PBT 45,462 48,163 32,758 12,431 81,436 53,948 44,521 1.40%
Tax -15,152 -15,901 -8,931 -3,122 -19,709 -14,337 -11,305 21.49%
NP 30,310 32,262 23,827 9,309 61,727 39,611 33,216 -5.90%
-
NP to SH 30,384 32,640 24,054 9,307 60,191 38,279 32,219 -3.82%
-
Tax Rate 33.33% 33.01% 27.26% 25.11% 24.20% 26.58% 25.39% -
Total Cost 1,348,038 969,970 644,068 308,251 1,239,069 937,279 613,712 68.73%
-
Net Worth 421,524 424,715 417,306 439,675 431,158 407,610 400,063 3.53%
Dividend
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
Div 10,698 50,281 50,290 - 39,585 28,885 28,881 -48.32%
Div Payout % 35.21% 154.05% 209.07% - 65.77% 75.46% 89.64% -
Equity
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
Net Worth 421,524 424,715 417,306 439,675 431,158 407,610 400,063 3.53%
NOSH 106,985 106,981 107,001 106,977 106,987 106,984 106,968 0.01%
Ratio Analysis
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
NP Margin 2.20% 3.22% 3.57% 2.93% 4.75% 4.05% 5.13% -
ROE 7.21% 7.69% 5.76% 2.12% 13.96% 9.39% 8.05% -
Per Share
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
RPS 1,288.35 936.83 624.19 296.85 1,215.84 913.11 604.78 65.33%
EPS 28.40 30.51 22.48 8.70 56.26 35.78 30.12 -3.83%
DPS 10.00 47.00 47.00 0.00 37.00 27.00 27.00 -48.33%
NAPS 3.94 3.97 3.90 4.11 4.03 3.81 3.74 3.52%
Adjusted Per Share Value based on latest NOSH - 106,977
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
RPS 95.64 69.54 46.34 22.03 90.26 67.78 44.89 65.34%
EPS 2.11 2.26 1.67 0.65 4.18 2.66 2.24 -3.89%
DPS 0.74 3.49 3.49 0.00 2.75 2.00 2.00 -48.36%
NAPS 0.2925 0.2947 0.2895 0.3051 0.2992 0.2828 0.2776 3.53%
Price Multiplier on Financial Quarter End Date
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
Date 30/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 -
Price 5.31 4.98 4.98 4.27 4.00 4.09 3.80 -
P/RPS 0.41 0.53 0.80 1.44 0.33 0.45 0.63 -24.84%
P/EPS 18.70 16.32 22.15 49.08 7.11 11.43 12.62 29.88%
EY 5.35 6.13 4.51 2.04 14.07 8.75 7.93 -23.02%
DY 1.88 9.44 9.44 0.00 9.25 6.60 7.11 -58.70%
P/NAPS 1.35 1.25 1.28 1.04 0.99 1.07 1.02 20.48%
Price Multiplier on Announcement Date
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
Date 25/02/11 04/11/10 11/08/10 26/05/10 19/02/10 13/11/09 21/08/09 -
Price 5.35 4.92 4.95 4.71 4.05 3.93 4.00 -
P/RPS 0.42 0.53 0.79 1.59 0.33 0.43 0.66 -25.95%
P/EPS 18.84 16.13 22.02 54.14 7.20 10.98 13.28 26.17%
EY 5.31 6.20 4.54 1.85 13.89 9.10 7.53 -20.72%
DY 1.87 9.55 9.49 0.00 9.14 6.87 6.75 -57.40%
P/NAPS 1.36 1.24 1.27 1.15 1.00 1.03 1.07 17.28%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment